A new UCSF study shows a significant increase in advanced prostate cancer cases in California, growing faster than the ...
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...
Advanced prostate cancer cases are rising sharply in California, outpacing national trends, according to a new study from ...
A new study by UC San Francisco found that prostate cancer cases are increasing in California, likely due to a change in ...
On January 7, 2025, the FDA granted priority review to the new drug application for sunvozertinib (DZD9008), an oral EGFR ...
First Focal One® procedure utilizing Cortechs.ai’s advanced MRI-imaging technology, OnQ Prostate, successfully performed at the University of ...
A small, early trial of a vaccine that mobilizes the immune system to battle advanced kidney cancers appears successf ...
A study found no significant HRQOL differences between Erleada-based therapies and ADT plus AAP for advanced castration-sensitive prostate cancer.
Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...
At the New Mexico Cancer Center in Albuquerque, groundbreaking treatments and compassionate care are helping change the lives ...
Men with prostate cancer are living longer than ever, and our goal is to reduce the risk of late toxicities, such as difficulty urinating or rectal bleeding, that can impact a patient’s quality of ...